Results 2,221-2,240 of 3,998 for speaker:Michael Harty
- Joint Oireachtas Committee on Health: Cancer Screening Programmes: Discussion (23 May 2018)
Michael Harty: I ask Deputy Kelly to concentrate on the questions.
- Joint Oireachtas Committee on Health: Cancer Screening Programmes: Discussion (23 May 2018)
Michael Harty: I thank Ms Culliton. I ask Deputy Kelly to move on.
- Joint Oireachtas Committee on Health: Cancer Screening Programmes: Discussion (23 May 2018)
Michael Harty: We have to move on because we have another important meeting.
- Joint Oireachtas Committee on Health: Cancer Screening Programmes: Discussion (23 May 2018)
Michael Harty: I thank Deputy Kelly. I will take a brief question from Senator Colm Burke. We will then take a question from Deputy Durkan, followed by Deputy Bríd Smith and then we will conclude the meeting. I ask Senator Burke to keep his question brief.
- Joint Oireachtas Committee on Health: Cancer Screening Programmes: Discussion (23 May 2018)
Michael Harty: I thank Dr. Lambkin.
- Joint Oireachtas Committee on Health: Cancer Screening Programmes: Discussion (23 May 2018)
Michael Harty: That would obviously have capacity implications.
- Joint Oireachtas Committee on Health: Cancer Screening Programmes: Discussion (23 May 2018)
Michael Harty: When smears go to Medlab, they are not necessarily read in Ireland, are they?
- Joint Oireachtas Committee on Health: Cancer Screening Programmes: Discussion (23 May 2018)
Michael Harty: They could be outsourced?
- Joint Oireachtas Committee on Health: Cancer Screening Programmes: Discussion (23 May 2018)
Michael Harty: It is important to remember that cervical screening saves lives and has saved a significant number of lives over the past ten years. The issue we are dealing with is quality control and how those who were missed were dealt with. It is very important that we maintain confidence in the cervical screening programme because it saves lives. Cervical screening picks up early changes, people are...
- Joint Oireachtas Committee on Health: Cancer Screening Programmes: Discussion (23 May 2018)
Michael Harty: On behalf of the committee, I thank the witnesses from the Academy of Clinical Science and Laboratory Medicine and the Medical Laboratory Scientists Association for coming in to give evidence. Those names are tongue twisters. We will suspend for a few moments to allow our next group of witnesses to join us.
- Joint Oireachtas Committee on Health: Cancer Screening Programmes: Discussion (23 May 2018)
Michael Harty: The purpose of this second session is to meet representatives from the BreastCheck screening programme to establish its effectiveness. I welcome Professor Arnold Hill, Mr. Damien McCallion, Professor Risteárd Ó Laoide and Professor Ann O'Doherty and thank them for their attendance. I draw the witnesses' attention to the fact that by virtue of section 17(2)(l) of the Defamation Act...
- Joint Oireachtas Committee on Health: Cancer Screening Programmes: Discussion (23 May 2018)
Michael Harty: Is there an organised programme of audit carried out on interval cancers that occur between one mammogram and the diagnosis of cancer? I am quite surprised to hear that there is no policy of open disclosure in respect of BreastCheck because that has been the central issue that we have been dealing with in respect of CervicalCheck. It has been a policy of the HSE since 2013 and within the...
- Joint Oireachtas Committee on Health: Cancer Screening Programmes: Discussion (23 May 2018)
Michael Harty: So 7% are brought back but only one tenth of those will have cancer lesions.
- Joint Oireachtas Committee on Health: Cancer Screening Programmes: Discussion (23 May 2018)
Michael Harty: In what percentage of cases was evidence of lesions in previous mammograms not picked up?
- Joint Oireachtas Committee on Health: Cancer Screening Programmes: Discussion (23 May 2018)
Michael Harty: I thank the witnesses for their contributions. We will now move to questions from members and I ask members to confine their contributions to ten minutes.
- Joint Oireachtas Committee on Health: Cancer Screening Programmes: Discussion (23 May 2018)
Michael Harty: I thank Professor Hill.
- Joint Oireachtas Committee on Health: Cancer Screening Programmes: Discussion (23 May 2018)
Michael Harty: The Deputy can come back in on that question later.
- Joint Oireachtas Committee on Health: Cancer Screening Programmes: Discussion (23 May 2018)
Michael Harty: Let us concentrate on Deputy Kelly's question.
- Joint Oireachtas Committee on Health: Cancer Screening Programmes: Discussion (23 May 2018)
Michael Harty: I wish to consider Deputy Kelly's question. The committee has been experiencing the response to this during the past month. If there was a policy of open disclosure that was delivered the moment an issue arose, then perhaps Professor O'Doherty would not have the flood of 15 cases coming down the line in a two-week period rather than one per year. If there is open disclosure, patients are...
- Joint Oireachtas Committee on Health: Cancer Screening Programmes: Discussion (23 May 2018)
Michael Harty: I thank Professor O'Doherty. I call Senator Colm Burke and he will be followed by Deputy Durkan. I ask members to be brief as we under time pressure.